跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial
Approved
STANDARD
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
3aa7571b53c2bdf6
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
3aa7571b53c2bdf6
Product Name
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial
Artg Id
375461
Artg Name
SUGAMMADEX-TEVA sugammadex (as sodium) 200 mg/2 mL solution for injection vial
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2023-03-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d54f485ac6fc1b7a8b3e6e2d81acda11.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/14b644a33cb7024126436976f43e253d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
3aa7571b53c2bdf6
Type
Standard
Back to TGA Approvals